The gut microbiome has been implicated in a variety of chronic conditions, including obesity, type 2 diabetes, inflammatory bowel disease (IBD), and certain autoimmune diseases. Imbalances in the gut microbiome, known as dysbiosis, can contribute to these conditions. Research suggests that restoring a balanced gut microbiome through interventions such as probiotic supplementation, prebiotic consumption, or dietary changes may be beneficial in managing or preventing these chronic conditions. However, more research is needed to fully understand the complex relationship between the gut microbiome and chronic diseases.
Title : Results from a cross-sectional observational study examining irritable bowel syndrome patients six months after finishing their participation in the ViIBS trial
Jacek Piatek, Calisia University, Poland
Title : Gut microbiome as a driver of healthy ageing
Thi Thu Hao Van, RMIT University, Australia
Title : Treating irritable bowel syndrome patients with a balanced multi-strain synbiotic–results from a multi-center, randomized, double-blind, placebo-controlled clinical trial (the ViIBS trial)
Henning Sommermeyer, Calisia University, Poland
Title : Molecular mechanisms underlying the anti-atherogenic actions of probiotics
Dipak P Ramji, Cardiff University, United Kingdom
Title : Global regulatory trends on the use of probiotics and prebiotics in foods and food supplements
David Pineda Ereno, DPE International Consulting, Belgium
Title : Biochemical profile and nutripotential glimpses of Terminalia arjuna bark extract
Suriyavathana Muthukrishnan, Periyar University, India